Health Care & Life Sciences » Pharmaceuticals | Sinopharm Group Co. Ltd.

Sinopharm Group Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
21,831
24,230
29,325
34,134
40,660
54,200
Total Accounts Receivable
66,376
84,022
78,034
78,905
90,668
121,652
Inventories
21,392
25,385
26,917
28,738
32,134
40,356
Other Current Assets
5,413
4,641
6,437
6,335
10,414
17,172
Total Current Assets
115,012
138,278
140,714
148,112
173,877
233,379
Net Property, Plant & Equipment
8,172
8,878
9,121
7,533
9,358
12,573
Total Investments and Advances
1,492
2,050
2,207
4,686
7,225
8,722
Long-Term Note Receivable
-
-
1,850
4,226
-
11
Intangible Assets
7,177
7,935
8,024
7,009
8,012
8,526
Other Assets
2,735
3,409
3,722
3,500
4,046
4,429
Total Assets
135,063
160,817
166,410
175,950
203,522
268,863
ST Debt & Current Portion LT Debt
40,130
49,081
53,214
43,344
54,190
Accounts Payable
43,371
50,862
51,718
56,069
61,984
Income Tax Payable
594
743
1,151
1,423
1,064
Other Current Liabilities
6,686
6,882
8,042
10,435
15,864
Total Current Liabilities
90,781
107,568
114,125
111,271
133,101
Long-Term Debt
5,295
5,278
726
12,423
6,633
Provision for Risks & Charges
639
1,259
1,231
1,109
1,017
Deferred Taxes
241
479
55
212
204
Other Liabilities
230
399
554
680
304
Total Liabilities
97,660
115,249
117,463
126,155
141,856
Common Equity (Total)
27,941
34,227
35,937
35,490
42,325
Total Shareholders' Equity
27,941
34,227
35,937
35,490
42,325
Total Equity
36,645
45,361
48,789
49,682
61,546
Liabilities & Shareholders' Equity
135,063
160,817
166,410
175,950
203,522
Accumulated Minority Interest
8,704
11,134
12,852
14,193
19,222
Non-Equity Reserves
758
206
159
113
120

About Sinopharm Group Co.

View Profile
Address
Sinopharm Plaza
Shanghai Shanghai 200051
China
Employees -
Website http://www.sinopharmholding.com
Updated 07/08/2019
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers.